Compare DNA & MAGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DNA | MAGN |
|---|---|---|
| Founded | 2008 | 1864 |
| Country | United States | United States |
| Employees | N/A | 2980 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 458.6M | 435.4M |
| IPO Year | 2020 | 1994 |
| Metric | DNA | MAGN |
|---|---|---|
| Price | $6.94 | $11.99 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 1 |
| Target Price | $8.50 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 1.2M | 366.4K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 46.49 | 7.64 |
| EPS | N/A | ★ N/A |
| Revenue | $170,155,000.00 | ★ $3,204,000,000.00 |
| Revenue This Year | N/A | $5.37 |
| Revenue Next Year | N/A | $3.47 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 46.50 |
| 52 Week Low | $5.37 | $7.82 |
| 52 Week High | $17.58 | $15.52 |
| Indicator | DNA | MAGN |
|---|---|---|
| Relative Strength Index (RSI) | 44.55 | 43.24 |
| Support Level | $6.30 | $11.64 |
| Resistance Level | $7.10 | $12.96 |
| Average True Range (ATR) | 0.47 | 0.50 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 27.47 | 21.93 |
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
Magnera Corp is a supplier of a diverse portfolio of specialty materials comprised of organic and synthetic raw ingredients. The company markets its own products predominantly into stable, consumer-oriented end markets, including wipes, healthcare, adult incontinence, apparel, baby, feminine care, air filtration, and food and beverage, for disposable and durable applications. It also provides technical solutions in infrastructure markets. The company's operations are organized into two operating and reportable segments: Americas and Rest of World. It derives the majority of its revenue from the Americas, which manufactures products and components of personal care, including medical garments, wipes, dryer sheets, filtration, baby diapers and adult incontinence.